Advertisement

Pharmaceutical Chemistry Journal

, Volume 28, Issue 6, pp 372–391 | Cite as

Platelet activation factor analogs and antagonists

  • M. A. Sablina
  • I. P. Ushakova
  • G. A. Serebrennikova
The Search for New Therapeutic Agents
  • 14 Downloads

Keywords

Organic Chemistry Activation Factor Platelet Activation Platelet Activation Factor Factor Analog 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    F. F. Dergousov, T. I. Kuznetsova, and V. I. Kulikov, Khim.-farm. Zh.,24, No. 9, 48–50 (1990).Google Scholar
  2. 2.
    S. K. Bhatia and J. Hajdu, Synthesis, No. 1, 16–20 (1989).Google Scholar
  3. 3.
    S. K. Bhatia and J. Hajdu, Tetrahedron Lett.,28, No. 16, 1729–1732 (1987).Google Scholar
  4. 4.
    H. Brachwitz, P. Langen, D. Arndt, et al., Lipids,22, No. 11, 897–903 (1987).Google Scholar
  5. 5.
    P. Braquet and J. J. Godfroid, Platelet Activating Factor and Related Lipid Mediators, F. Snyder (ed.), New York (1987), pp. 191–235.Google Scholar
  6. 6.
    J. J. Godfroid and F. Heymans, Progress in Biochemical Pharmacology, Vol. 22, Biologically Active Lipids, K. K. Carroll (ed.), Basel (1988), pp. 25–34.Google Scholar
  7. 7.
    B. Hofmann, G. Ostermann, H.-P. Kertscher, et al., Thrombos. Res.,49, 415–423 (1988).Google Scholar
  8. 8.
    W. J. Houlihan, M. L. Lee, P. G. Munder, et al., Lipids.22, No. 11, 884–890 (1987).Google Scholar
  9. 9.
    European Patent 255,366; MKI CO7C147/02. Preparation of Nitrogen- and Sulfur-Containing Lipid Compounds as Antitumor Agents and PAF Antagonists, K. Inoue, H. Nomura, and T. Aono, Published February 3, 1988.Google Scholar
  10. 10.
    V. Jestet-Lamaut, B. Archaimbault, J. Durand, et al., Biochim. Biophys. Acta,1123, No. 3, 347–350 (1992).Google Scholar
  11. 11.
    European Patent 321,296; MKI CO7D249/14. Lipid Derivatives: Their Preparation and Use, S. Kamata, T. Matsui, T. Tsuri, et al., Published June 21, 1989; Otkrytiya, No. 25, (1989).Google Scholar
  12. 12.
    I. Kudo, S. Nojima, H.-W. Chang, et al., Lipids22, No. 11, 862–867 (1987).Google Scholar
  13. 13.
    J. Lamotte-Brasseur, G. Dive, A. Lamouri, et al., Biochim. Biophys. Acta, 1085, No. 1, 91–105 (1991).Google Scholar
  14. 14.
    R. Levi, A. Genovese, and R. N. Pinkard, Biochem. Biophys. Res. Commun.,161, No. 3, 1341–1347 (1989).Google Scholar
  15. 15.
    USA Patent 4,702,864; NKI 260-402.5 (MKI C08H3/00). Preparation and Testing of Analogs of PAF as Antiinflammatories, Antihypertensives and Phospholipase A2 Inhibitors, R. L. Magolda, P. N. Confalone, and P. R. Johnson; Published October 27, 1987.Google Scholar
  16. 16.
    S. Morris-Natschke, J. R. Surles, L. W. Daniel, et al., J. Med. Chem.,29, 2114–2117 (1986).Google Scholar
  17. 17.
    N. Nakamura, H. Miyazaki, N. Ohkawa, et al., Tetrahedron Lett.,31, No. 5, 699–702 (1990).Google Scholar
  18. 18.
    J. T. O'Flaherty, J. F. Redman, J. D. Schmitt, et al., Biochem. Biophys. Res. Commun.,147, No. 1, 18–24 (1987).Google Scholar
  19. 19.
    M. Ohno, K. Fujita, M. Shiraiwa, et al., J. Med. Chem.,29, 1812–1814 (1986).Google Scholar
  20. 20.
    European Patent 353,474 MKI CO7D213/40. Preparation of Glycerol Derivatives as Platelet Activating Factor (PAF) Antagonists, K. Okano, O. Asano, N. Shimonura, et al., Published February 7, 1990; Otkrytiya No. 6, (1990).Google Scholar
  21. 21.
    T. Rosario-Jansen, R.-T. Jiang, and M.-D. Tsai, Biochemistry,27, 4619–4624 (1988).Google Scholar
  22. 22.
    T. T. Shen, S.-B. Hwang, T. W. Doebber, et al., Platelet Activating Factor and Related Lipid Mediators, F. Snyder (ed.) New York (1987), pp. 153–190.Google Scholar
  23. 23.
    F. Snyder, Platelet Activating Factor and Related Lipid Mediators, F. Snyder (Ed.) New York (1987), pp. 89–113.Google Scholar
  24. 24.
    F. Snyder, T. Ch. Lee, and M. L. Blank, Ann. N. Y. Acad. Sci.,568, 35–43 (1989).Google Scholar
  25. 25.
    Patent PCT 89/07099, MKI CO 7D277/22. 2,2-Distributed Glycerol and Glycerol-Like Compounds, Compositions and Methods for Use, D. M. Solomon and J. J. Kaminski, Published August 10, 1989.Google Scholar
  26. 26.
    Patent PCT 89/07100, MKI C07D277/22. 2,2-Distributed Glycerol and Glycerol-Like Compounds, Compositions and Methods for Use, D. M. Solomon and J. J. Kaminski, Published August 10, 1989.Google Scholar
  27. 27.
    R. P. Srivastava and J. Hajdu, Tetrahedron Lett.,32, No. 45, 6525–6528 (1991).Google Scholar
  28. 28.
    U. Valeavi, R. Aveta, A. Brandt, et al., Lipids,22, No. 11, 327–332 (1987).Google Scholar
  29. 29.
    B. Wichrowski, S. Jouquey, C. Broquet, et al., J. Med. Chem.,31, No. 2, 411 (1988).Google Scholar
  30. 30.
    A. Wissner, R. E. Schaub, P.-E. Sum. et al., J. Med. Chem.,29, 328–333 (1986).Google Scholar
  31. 31.
    A. Wissner, C. A. Kohler, and B. M. Goldstein, J. Med. Chem.,29, 1315–1319 (1986).Google Scholar
  32. 32.
    European Patent 336,142, MKI C07F9/12. Novel Antagonists of Platelet Activating Factor, A. Wissner, R. E. Schaub, and P.-E. Sum, Published October 11, 1989; Otkrytiya No. 41 (1989).Google Scholar
  33. 33.
    K. Yamauchi, M. Hihara, M. Kinoshita, et al., Bull. Chem. Soc. Jpn.,62, No. 3, 969–971 (1989).Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • M. A. Sablina
    • 1
  • I. P. Ushakova
    • 1
  • G. A. Serebrennikova
    • 1
  1. 1.M. V. Lomonosov Moscow Institute of Fine ChemistryUSSR

Personalised recommendations